LINDON, UT--(Marketwire - Aug 2, 2012) - ZYTO Corp (OTCBB: ZYTC) www.ZYTO.com.
ZYTO Corp, a Utah-based biotech company specializing in biocommunication applications, today announced that Dr. David Lee, DC, PhD, CAd, has joined its Scientific Advisory Board.
Vaughn R Cook, OMD, ZYTO's Chief Executive Officer, said, "Dr. Lee is a highly-regarded physician with extensive experience in the field of integrative medicine. We are looking forward to his input and guidance as we reach new levels of success with our technology."
"Dr. Lee's passion for our technology and his broad range of credentials and certifications in this field of medicine will assist us in advancing our technology and research initiatives," said Kami J. Howard, ZYTO's President.
Dr. Lee operates a private practice in Atlanta, Georgia. He is a licensed Chiropractor Doctor in Georgia and a Licensed Chiropractic Physician in Florida. He consults and lectures extensively and is a frequent guest speaker on radio and television programs.
The other members of ZYTO's Scientific Advisory Board are: Lee Cowden, MD; Dennis Cozzocrea, DC; Jane Oelke, ND, PhD; and Bruce H. Shelton, MD, MD(H), DiHOM, FBIH.
For background and biographical information on each Scientific Advisory Board member, please visit http://www.ZYTO.com/advisoryboard.html.
The Scientific Advisory Board meets periodically throughout the year to provide direction, clinical insights, and recommendations to improve current and future ZYTO initiatives. The next meeting will be held in October, 2012.
About ZYTO Corp
ZYTO Corp was founded by its CEO Dr. Vaughn R Cook, OMD. The company designs and builds computer technology to facilitate decision making about healthcare and wellness options.
For more information visit www.ZYTO.com or contact their Headquarters at 801-224-7199.
Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to marketing and sales activities by ZYTO's marketing partners, ZYTO product development launches, future growth and research, future success, and enhanced value for ZYTO's stockholders are forward-looking statements. Such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company's products, increased levels of competition, new products and technological changes, dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time in the Company's periodic reports. ZYTO disclaims any obligation or intention to update any forward-looking statement contained in this release.